default author photo

Jackton Indangasi

Mwanza Intervention Trials Unit

Mwanza

Tanzania

  • Mwanza Intervention Trials Unit

SCHOLARLY PAPERS

3

DOWNLOADS

457

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls - the DoRIS Randomised Trial

Number of pages: 130 Posted: 11 Mar 2022
Deborah Watson-Jones, John Changalucha, Hilary Whitworth, Ligia A. Pinto, Paul Mutani, Jackton Indangasi, Troy J. Kemp, Ramadhan Hashim, Beatrice Kamala, Rebecca Wiggins, Twaib Songoro, Nicholas Connor, Gladys Mbwanji, Miquel Pavon, Brett Lowe, Devis Mmbando, Saidi Kapiga, Philippe Mayaud, Silvia de SanJosé, Joakim Dillner, Richard J. Hayes, Charles Lacey and Kathy Baisley
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Mwanza Intervention Trials Unit, University of York, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, Gran Via de l'Hospitale, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Clinical Research, Institut Català d'Oncologia - Cancer Epidemiology Research Programme, Karolinska Institutet - Department of Laboratory Medicine, London School of Hygiene & Tropical Medicine - MRC International Statistics & Epidemiology Group, University of York - York Biomedical Research Institute and London School of Hygiene & Tropical Medicine - Faculty of Epidemiology and Population Health
Downloads 179 (422,345)

Abstract:

Loading...

HPV vaccine, dose schedules, immunogenicity, Africa

2.

Comparison of Immune Responses after One Dose of HPV Vaccine in a Dose-Reduction HPV Vaccine Trial in Adolescent Girls in Tanzania to the Costa Rica Vaccine and India HPV Vaccine Trials

Number of pages: 26 Posted: 11 Mar 2022
Kathy Baisley, Troy J. Kemp, Aimée R. Kreimer, Partha Basu, John Changalucha, Allan Hildesheim, Carolina Porras, Hilary Whitworth, Rolando Herrero, Charles Lacey, John T. Schiller, Eric Lucas, Paul Mutani, Joakim Dillner, Jackton Indangasi, Richard Muwonge, Richard J. Hayes, Ligia A. Pinto and Deborah Watson-Jones
London School of Hygiene & Tropical Medicine - Faculty of Epidemiology and Population Health, Government of the United States of America - HPV Serology Laboratory, Government of the United States of America - Division of Cancer Epidemiology and Genetics, World Health Organization (WHO) - Early Detection, Prevention and Infections Branch, Mwanza Intervention Trials Unit, Government of the United States of America - Division of Cancer Epidemiology and Genetics, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Fundacion INCIENSA - Agencia Costarricense de Investigaciones Biomedicas (ACIB), University of York - York Biomedical Research Institute, Government of the United States of America - Division of Cancer Epidemiology and Genetics, World Health Organization (WHO) - Early Detection, Prevention and Infections Branch, Mwanza Intervention Trials Unit, Karolinska Institutet - Department of Laboratory Medicine, Mwanza Intervention Trials Unit, World Health Organization (WHO) - Early Detection, Prevention and Infections Branch, London School of Hygiene & Tropical Medicine - MRC International Statistics & Epidemiology Group, Government of the United States of America - HPV Serology Laboratory and Mwanza Intervention Trials Unit
Downloads 175 (431,126)

Abstract:

Loading...

HPV vaccine, immunobridging, vaccine efficacy, Africa

3.

Durability of Immunogenicity at 5 Years after a Single Dose of HPV Vaccine Compared with 2 Doses in Tanzanian Girls Aged 9-14 Years:  Results of the Long-Term Extension of the DoRIS Randomised Trial

Number of pages: 28 Posted: 23 Apr 2024
Deborah Watson-Jones, John Changalucha, Caroline Maxwell, Hilary Whitworth, Paul Mutani, Troy J. Kemp, Beatrice Kamala, Jackton Indangasi, George Constantine, Ramadhan Hashim, David Mwanzalima, Rebecca Wiggins, Devis Mmbando, Nicholas Connor, Miquel Pavon, Brett Lowe, Saidi Kapiga, Philippe Mayaud, Silvia de Sanjose, Joakim Dillner, Richard J. Hayes, Charles Lacey, Ligia A. Pinto and Kathy Baisley
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Mwanza Intervention Trials Unit, University of York, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine, Gran Via de l'Hospitale, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Clinical Research, National Institutes of Health, ISGlobal, Karolinska Institutet - Department of Laboratory Medicine, London School of Hygiene & Tropical Medicine - MRC International Statistics & Epidemiology Group, University of York - York Biomedical Research Institute, Government of the United States of America - HPV Serology Laboratory and London School of Hygiene & Tropical Medicine - Faculty of Epidemiology and Population Health
Downloads 103 (674,591)

Abstract:

Loading...

HPV vaccine, adolescent health, Tanzania, single dose